Oldies but Goodies: Thiazolidinedione as an Insulin Sensitizer with Cardioprotection

被引：5
|
作者：
Cho, Eun-Hee [1 ,2 ]
机构：
[1] Kangwon Natl Univ, Dept Internal Med, Sch Med, Chunchon, South Korea
[2] Kangwon Natl Univ, Dept Internal Med, Sch Med, 1 Gangwondaehak gil, Chunchon 24341, South Korea
来源：
DIABETES & METABOLISM JOURNAL | 2022年 / 46卷 / 06期
关键词：
CLINICAL-TRIAL; PIOGLITAZONE; METFORMIN; DRUG;
D O I：
10.4093/dmj.2022.0372
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：827 / 828
页数：2
相关论文
共 50 条
  • [21] Hybridization of non-sulfonylurea insulin secretagogue and thiazolidinedione-derived insulin sensitizer
    Kitajima, H
    Nakamura, M
    Tamakawa, H
    Goto, N
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (21) : 2453 - 2456
  • [22] Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans
    Cox, PJ
    Ryan, DA
    Hollis, FJ
    Harris, AM
    Miller, AK
    Vousden, M
    Cowley, H
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (07) : 772 - 780
  • [23] Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARγ agonist) action
    Zierath, JR
    Ryder, JW
    Doebber, T
    Woods, J
    Wu, M
    Ventre, J
    Li, ZH
    McCrary, C
    Berger, J
    Zhang, B
    Moller, DE
    ENDOCRINOLOGY, 1998, 139 (12) : 5034 - 5041
  • [24] Oldies but goodies: New ways of making valuable older information accessible
    Smithies, A
    Voyages of Discovery: Parting the Seas of Information Technology, 2005, : 219 - 222
  • [25] Hybridization of non-sulfonylurea insulin secretagogue and thiazolidinedione-derived insulin sensitizer.
    Kitajima, H
    Nakamura, M
    Tamakawa, H
    Gotoh, N
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U645 - U645
  • [26] WHY EVERYBODY LOVES A WHITE-HOUSE CONFERENCE - GOODIES FOR OLDIES
    CHAPMAN, S
    NEW REPUBLIC, 1981, 184 (1-2) : 9 - 11
  • [27] Culture-based Omics Approaches in Biostimulants and Food Microbiomes: Oldies but Goodies?
    Chang, Woo-Suk
    2019 13TH IEEE INTERNATIONAL CONFERENCE ON NANO/MOLECULAR MEDICINE & ENGINEERING (IEEE-NANOMED 2019), 2019, : 57 - 57
  • [28] Pharmacological characteristics of a novel non-thiazolidinedione insulin sensitizer, FK614
    Minoura, H
    Takeshita, S
    Ita, M
    Hirosumi, J
    Sakuma, H
    Fujimura, T
    Aramori, I
    Suzuki, A
    Fukagawa, M
    Kojo, H
    Sawada, H
    Imoto, T
    Takakura, S
    Kawamura, I
    Mutoh, S
    Seki, J
    Goto, T
    DIABETES, 2001, 50 : A518 - A518
  • [29] Absorption, Distribution, Metabolism and Excretion (ADME) Study With a Potent Thiazolidinedione Insulin Sensitizer, Lobeglitazone
    Kim, Se-Mi
    Ha, Nina
    Park, Kyu-Tae
    Oh, Hyun-Tak
    Yu, Hosung
    Kim, Young Min
    Lee, Sungsook
    Kim, Dal-Hyun
    DRUG METABOLISM REVIEWS, 2010, 42 : 275 - 276
  • [30] An herbal cocktail serves as a novel insulin sensitizer but shares divergent mechanism with those of thiazolidinedione agents
    Zou, Chenhui
    Sun, Sujuan
    Chen, Yueteng
    Zhang, Ning
    Shen, Zhufang
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 300 - 300
12345